Target intelligence / Profile preview

GRB2-associated binding protein 4 (GAB4)

Target
GAB4
Molecular classification
Adaptor protein, Docking protein, Pleckstrin homology domain containing protein, Other
01

Overview

GRB2-associated binding protein 4 (GAB4) is a member of the GAB family of adaptor or docking proteins, which includes GAB1, GAB2, and GAB3. GAB4 is predicted to enable transmembrane receptor protein tyrosine kinase adaptor activity, functioning in intracellular signaling pathways related to receptor tyrosine kinases. However, while GAB1, GAB2, and GAB3 are well characterized—with GAB2, in particular, known to play important roles in leukemogenesis, cancer biology, and multiple signaling pathways—GAB4 remains poorly described in the published literature. There is no direct evidence that GAB4 serves as a validated therapeutic target, has known endogenous or drug ligands, or plays a direct role in human disease[3][4][5]. Most available information on GAB4 is inferred from its membership in the GAB protein family and predicted bioinformatic functions, rather than from experimental characterization or therapeutic research. Clarification: - The provided target, GRB2-associated binding protein 4 (GAB4), is not currently recognized as a validated or well-characterized therapeutic target. Most functional and disease associations are based on predictions or homology to other family members such as GAB2, which *is* therapeutically relevant and well-studied in cancer and signal transduction[1][2]. - There are no known drugs, mechanisms of action, or biomarker uses for GAB4 itself. - The target entry is likely conflated or confused with GAB2, which has extensive literature, whereas GAB4 has only sparse, predicted data. - No safety or efficacy data is available because GAB4 is not used as a therapeutic target. Summary: GAB4 is an adaptor/docking protein of the GAB family, predicted to serve as a signaling scaffold for receptor tyrosine kinases, but it is not a validated therapeutic target, and much of its function, disease association, and druggability remains to be determined[3][4][5]. The current entry may reflect a case of mistaken identity with the functionally established GAB2.

Other names
GRB2-associated-binding protein family member 4GAB4GAB2-likeGRB2-associated binder 2-likeGRB2-associated binder 4GRB2-associated-binding protein 2-likeGrowth factor receptor bound protein 2-associated protein 4GAB2-like proteingrowth factor receptor bound protein 2-associated protein 4
02

Biological functions

Predicted function as an adaptor for transmembrane receptor protein tyrosine kinases[3][4]signal transduction (predicted)may be involved in intracellular signaling

Beyond the preview

Go deeper on GRB2-associated binding protein 4 (GAB4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GRB2-associated binding protein 4 (GAB4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call